USA: impact stop Janssen vaccine limited

The temporary stop on the use of Janssens corona vaccine has only a limited impact on the vaccination program in the United States. Thats what Jeff Zents, the coordinator of American coronation policy, said.

As a

precaution, the United States temporarily stop Janssens vaccine from Leiden after six people experienced a rare and dangerous combination of blood clots (thrombosis) and low platelets after vaccination. It concerns six women between 18 and 48 years of age who had blood clots in the brain between six and thirteen days after vaccination. One of them has died and another is in critical condition in a hospital, said Peter Marks of regulator FDA.

He made a comparison with the AstraZeneca vaccine, with similar problems. It is not used in the USA.

More than

6.8 million

people in the United States have received the Janssen vaccine so far, less than 5 percent of the total number of pricks. The US says it has or has been supplied enough doses of Pfizer/Biontech and Moderna vaccines to keep up with the pace of 3 million pricks a day. Anyone who would receive Janssens vaccine will be approached for a new appointment for a prick with one of the other vaccines.

The Janssen vaccine has so far been used only in the US. In Europe, the first parties have already been delivered, but further distribution has been postponed as a precautionary measure, said pharmaceutical company Johnson & Johnson, Janssens parent company.